Prairie Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Prairie Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Hold	0	–	–	–	99
2025 Q4	–	Sell	-2,561	Closed	-$294K	–	115
2025 Q3	$257K	Sell	2,561 -530	-17%	-$47.7K	0.11%	132
2025 Q2	$256K	Sell	3,091 -300	-9%	-$23.9K	0.11%	129
2025 Q1	$275K	Sell	3,391 -832	-20%	-$74.4K	0.14%	116
2024 Q4	$380K	Sell	4,223 -2,550	-38%	-$247K	0.18%	94
2024 Q3	$669K	Buy	6,773 +157	+2%	+$15.4K	0.33%	64
2024 Q2	$613K	Buy	6,616 +231	+4%	+$20.7K	0.31%	65
2024 Q1	$606K	Buy	+6,385	New	+$592K	0.28%	72

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prairie Wealth Advisors's XBI Position: Q1 2026 in Review

Prairie Wealth Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 0 shares worth $358K. The position accounts for 0.16% of the portfolio, ranked #99.

Prairie Wealth Advisors first reported a position in XBI in Q1 2024 and has held it in 7 quarters since. The position peaked at $669K in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Prairie Wealth Advisors held 0 shares of State Street SPDR S&P Biotech ETF worth $358K as of Q1 2026.
Prairie Wealth Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.16% of Prairie Wealth Advisors's portfolio in Q1 2026, its #99 holding.
Prairie Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 7 quarters since.
Prairie Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $669K in Q3 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Prairie Wealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.